Sign in with your email address username.


[Articles] Efficacy, safety, and immunogenicity of an oral recombinant vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial

The oral recombinant H pylori vaccine was effective, safe, and immunogenic in H pylori-naive children. This vaccine could substantially reduce the incidence of H pylori infection; however, follow up over a longer period is needed to confirm the protection of the vaccine against H pylori-associated diseases.